Typically patients presenting with just one symptom  associated with multiple sclerosis may be given a diagnosis of clinically isolated syndrome and left hanging without benefit of any of the disease modifying therapies that could slow progression of multiple sclerosis, which many of these patients end up developing. Now researchers have identified gene activity that shows which of these patients are most at risk for conversion to multiple sclerosis.